In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Kornelia Kotseva
Speaker
Kornelia Kotseva
Kornelia Kotseva Kornelia Kotseva

Imperial College Healthcare NHS Trust, London (United Kingdom of Great Britain & Northern Ireland)

Specialities : Risk Factors and Prevention , Cardiovascular Disease in Women, Chronic Heart Failure, Hypertension

Professor Kornelia Kotseva, MD, PhD, FESC holds an academic appointment at the National Institute for Prevention and Cardiovascular Health, National University of Ireland – Galway, and a position as a Consultant Cardiologist at the Imperial College Healthcare NHS Trust, London, UK. She has been Chair of the Steering Committee of the European Society of Cardiology EUROASPIRE surveys, aiming to describe the risk factor management in patients with coronary disease and in people at high cardiovascular risk in Europe. Furthermore, she was a Principal Investigator and led several other European and UK studies. She has won numerous prestigious awards and has authored more than 250 publications. She led the module on Cardiovascular Risk Estimation and was involved in the development of the Master’s programme on Cardiovascular Health and Disease Prevention, Imperial College London. Her main research and clinical interest is primary and secondary prevention of cardiovascular disease.

22 presentations from this speaker

Reaching lifestyle and risk factors targets in people at high cardiovascular risk in Europe – Temporary trends and state of the art

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2019

  • Session : Guidelines, clinical evidence and real life practice: how to find your way in managing patients at high cardiovascular risk?
  • Speaker : K Kotseva (London,GB)

New challenges in implementation of CVD prevention in clinical practice.

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2018

  • Session : What is new in the management of people with CHD? EUROASPIRE V survey on cardiovascular disease prevention and diabetes
  • Speaker : K Kotseva (London,GB)

Reaching lipid targets in coronary patents - Temporal trends and state of the art.

Event : ESC Congress 2018

  • Session : Implementation of cardiovascular disease prevention in daily practice - Insights from EUROASPIRE V
  • Speaker : K Kotseva (London,GB)

Achieving lipid or hypertension goals: how are we doing?

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2017

  • Session : Secondary Prevention: unmet medical needs - Session II
  • Speaker : K Kotseva (London,GB)

Attainment of blood pressure, lipids and diabetes targets in people at high cardiovascular risk in Europe: a report from the EUROASPIRE IV Survey

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2017

  • Session : Rapid Fire Abstract session II
  • Speaker : K Kotseva (London,GB)

Barriers to risk factor control and adherence to medical therapy after an ACS.

Event : Webinar 2017

  • Session : ACVC Webinars 2017
  • Speaker : S Halvorsen (Oslo,NO), K Kotseva (London,GB), G Tavazzi (Pavia,IT)

Reducing cardiovascular risk in hypertensive patients - When to use lipid lowering and antiplatelet therapy?

Event : ESC Congress 2017

  • Session : Improving cardiovascular outcome managing hypertension
  • Speaker : K Kotseva (London,GB)
  • Joint with the Brazilian Society of Cardiology

Management of overweight and obesity in patients at high cardiovascular risk across Europe: Results from EUROASPIRE IV survey

Event : ESC Congress 2016

  • Session : Breaking down barriers in secondary prevention
  • Speaker : K Kotseva (London,GB)

Using varenicline in cardiovacular disease

Event : ESC Congress 2016

  • Session : What works in smoking cessation in heart disease?
  • Speaker : K Kotseva (London,GB)

Cardiac rehabilitation for coronary patients in Europe: Results from the EUROASPIRE IV survey

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2015

  • Session : Rapid Fire Abstract Session II - Cardiac Rehabilitation & Exercise Basic & Translational Research
  • Speaker : K Kotseva (London,GB)

Lipids treatment in secondary prevention: lessons from EuroAspire

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2015

  • Session : Update on Lipid Lowering Therapy part 1: Why are some patients more difficult to treat with statins than others?
  • Speaker : K Kotseva (London,GB)

Management of overweight and obesity in patients with coronary heart disease across europe: results from euroaspire IV survey

Event : ESC Congress 2015

  • Session : Surveillance of risk factors and interventions
  • Speaker : K Kotseva (London,GB)

New challenges in a changing research environment.

Event : ESC Congress 2015

  • Session : How are we managing cardiovascular risk in the primary care environment? EUROASPIRE IV survey
  • Speaker : K Kotseva (London,GB)

Cardiovascular prevention in primary care: lessons from EUROASPIRE.

Event : ESC Congress 2014

  • Session : Cardiovascular disease prevention in 2014. Challenges for the future
  • Speaker : K Kotseva (London,GB)

My cardiovascular patient has dysglycaemia: what do I do? Case presentation.

Event : ESC Congress 2014

  • Session : Cardio-diabetology or diabeto-cardiology
  • Speaker : K Kotseva (London,GB)

EUROASPIRE IV: Clinical reality of coronary prevention in Europe: A comparison of EUROASPIRE II, III and IV surveys

Event : ESC Congress 2013

  • Session : Registry Hot Line: Registries on prevention and treatment
  • Speaker : K Kotseva (London,GB)

Medical risk factors results.

Event : ESC Congress 2013

  • Session : EUROASPIRE IV - principal results
  • Speaker : K Kotseva (London,GB)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are